Niamh Louise Pellegrini
CIK 1620611 · Chief Commercial Officer · last filed 2023-06-15
Niamh Louise Pellegrini is a Chief Commercial Officer who has filed 27 SEC Form 4 insider transactions across 3 companies since 2014. The most recent filing, for AFIB, was dated Jun 15, 2023. Across all open-market trades the lifetime net is −$1.6M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
3
27
-$1.55M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Acutus Medical, Inc. (AFIB) Delisted | Director | 20,972 | $0.09 | $1.9K | $0 | 3 | 2023-06-15 |
| NEVRO CORP (NVRO) Delisted | Chief Commercial Officer | 85,967 | $5.84 | $502.0K | -$1.55M | 21 | 2023-05-31 |
| THORATEC CORP (THOR) Delisted | President, North America | 51,928 | — | — | $0 | 3 | 2015-10-08 |
Recent Filings
27 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-06-15 | Acutus Medical, Inc. (AFIB) Delisted | Grant (A) | +8,400 | $0 | EDGAR |
| 2023-05-31 | NEVRO CORP (NVRO) Delisted | Tax (F) | −1,143 | -$30.2K | EDGAR |
| 2023-03-09 | NEVRO CORP (NVRO) Delisted | Grant (A) | +39,282 | $0 | EDGAR |
| 2023-03-06 | NEVRO CORP (NVRO) Delisted | Tax (F) | −1,979 | -$67.3K | EDGAR |
| 2023-03-02 | NEVRO CORP (NVRO) Delisted | Tax (F) | −4,718 | -$148.3K | EDGAR |
| 2022-08-08 | NEVRO CORP (NVRO) Delisted | Tax (F) | −4,365 | -$205.6K | EDGAR |
| 2022-06-21 | Acutus Medical, Inc. (AFIB) Delisted | Grant (A) | +8,400 | $0 | EDGAR |
| 2022-03-04 | NEVRO CORP (NVRO) Delisted | Tax (F) | −2,031 | -$144.7K | EDGAR |
| 2022-03-02 | NEVRO CORP (NVRO) Delisted | Grant (A) | +26,069 | $0 | EDGAR |
| 2021-08-12 | Acutus Medical, Inc. (AFIB) Delisted | Grant (A) | +4,172 | $0 | EDGAR |